Laxmi Organic Industries Limited has informed the Exchange regarding 'With respect to discrepancy received from Neaps portal regarding the Machine Readable Form of the Outcome of the Board Meeting dated July 28, 2025. Outcome of the Board Meeting held on July 28, 2025. We are submitting the Machine Readable format.'.
LXCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Laxmi Organic Industries reported Q1 FY26 (quarter ended June 30, 2025) results. Standalone revenue from operations fell to ₹6,719 million from ₹7,184 million a year ago, a decline of about 6.5%, while standalone profit after tax dropped sharply to ₹229.7 million from ₹352.1 million (down ~35%). Consolidated revenue was ₹6,929 million vs ₹7,182 million, with PAT at ₹213.9 million vs ₹343.5 million. Standalone basic EPS stood at ₹0.83 vs ₹1.28. Two items inflated reported profits: a change in depreciation method from Written Down Value to Straight Line (added ~₹245 million to PBT) and a one-time reversal of deferred tax liability of ~₹97 million after opting for the lower 25.17% tax rate under section 115BBA. Excluding the depreciation method change, standalone PBT would have been a loss of ~₹67 million. Prior period figures were restated to include the merged wholly-owned subsidiary Yellowstone Fine Chemicals, whose amalgamation became effective March 30, 2025. Auditors Deloitte Haskins & Sells LLP issued an unmodified limited review report.
Headline numbers look weak — both revenue and profits fell sharply year-on-year, and the actual operating performance was a loss before the accounting-driven boost from lower depreciation and tax-rate revision. Investors should look through these adjustments to assess underlying trends; the stock may face pressure given the steep earnings decline, though the tax/depreciation benefits provided temporary support to reported PAT.